A second US-guided biopsy was then suggested, and G3, ER-negative, PgR-negative, Ki67 = 75%, c-erb-2-positive (3+) invasive ductal carcinoma was confirmed. This evidence concerns the gene MKI67 and invasive ductal breast carcinoma.